{
    "root": "2e524986-7903-416f-b2b8-d27295103e75",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Doxazosin mesylate",
    "value": "20240311",
    "ingredients": [
        {
            "name": "DOXAZOSIN MESYLATE",
            "code": "86P6PQK0MU"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        }
    ],
    "indications": "Doxazosin is an alpha 1 adrenergic antagonist indicated for: • Signs and symptoms of Benign Prostatic Hyperplasia (BPH) ( 1.1 ) • Treatment of Hypertension ( 1.2 )",
    "contraindications": "• For the treatment of BPH: Initiate therapy at 1 mg once daily. Dose may be titrated at 1 to 2-week intervals, up to 8 mg once daily. ( 2.2 ) • For the treatment of hypertension: Initiate therapy at 1 mg once daily. Dose may be titrated as needed, up to 16 mg once daily. ( 2.3 )",
    "warningsAndPrecautions": "Doxazosin is available as tablets for oral administration. Each tablet contains Doxazosin mesylate equivalent to 1 mg (white), 2 mg (white), 4 mg (white) or 8 mg (white) of doxazosin as the free base.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              NDC and Pack Size\n                           \n                           \n                              Strength\n                           \n                           \n                              Description\n                           \n                        \n                        \n                           \n                              NDC 59762-1388-7 (Bottle of 100)\n                           \n                           \n                              1 mg\n                           \n                           \n                              White, round tablets with “CN1” on one side and “VLE” on the other side.\n                           \n                        \n                        \n                           \n                              NDC 59762-1389-7 (Bottle of 100)\n                           \n                           \n                              2 mg\n                           \n                           \n                              White, oblong tablets with score and “CN 2” on one side and “VLE” on the other side.\n                           \n                        \n                        \n                           \n                              NDC 59762-1390-7 (Bottle of 100)\n                           \n                           \n                              4 mg\n                           \n                           \n                              White, rhombus shaped tablets with break score and “CN 4” on one side and VLE on the other side.\n                           \n                        \n                        \n                           \n                              NDC 59762-1391-7 (Bottle of 100)\n                           \n                           \n                              8 mg\n                           \n                           \n                              White, capsule shaped tablets with break score and “CN 8” on one side and “VLE” on the other side.\n                           \n                        \n                     \n                  \n                  Recommended Storage: Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions": "The use of Doxazosin tablet is contraindicated in patients with a hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any of its components."
}